http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7d9b08904476d1bcf8fbbafe39c5830
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | K Sood Sood |
| name | Anil K. Sood Anil K Sood |
| given-name | Anil K. Anil Anil K |
| organization-name | Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Molecular and Cellular Oncology, and 3Cancer Biology, 4Center for RNA Interference and Non-Coding RNA, and 5Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas; Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Molecular and Cellular Oncology, and 3Cancer Biology, 4Center for RNA Interference and Non-Coding RNA, and 5Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas; Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Molecular and Cellular Oncology, and 3Cancer Biology, 4Center for RNA Interference and Non-Coding RNA, and 5Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Systems Biology, 3Pathology, 4Experimental Therapeutics, 5Bioinformatics and Computational Biology, 6Cancer Biology, 7Thoracic/Head and Neck Medical Oncology, and 8The Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Systems Biology, 3Pathology, 4Experimental Therapeutics, 5Bioinformatics and Computational Biology, 6Cancer Biology, 7Thoracic/Head and Neck Medical Oncology, and 8The Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Systems Biology, 3Pathology, 4Experimental Therapeutics, 5Bioinformatics and Computational Biology, 6Cancer Biology, 7Thoracic/Head and Neck Medical Oncology, and 8The Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas Authors' Affiliations: Departments of 1Obstetrics and Gynecology and 2Med/Hematology & Med Oncology and CTRC at The UT Health Science Center, San Antonio; Departments of 3Experimental Therapeutics, 4Gynecologic Oncology, 5Cancer Biology, and 6Center for RNA interference and non-coding RNA, University of Texas MD Anderson Cancer Center, Houston, Texas; and 7Department of Biochemistry and Cancer Center, University of Puerto Rico, Medical Science Campus, San Juan, Puerto Rico; Authors' Affiliations: Departments of 1Obstetrics and Gynecology and 2Med/Hematology & Med Oncology and CTRC at The UT Health Science Center, San Antonio; Departments of 3Experimental Therapeutics, 4Gynecologic Oncology, 5Cancer Biology, and 6Center for RNA interference and non-coding RNA, University of Texas MD Anderson Cancer Center, Houston, Texas; and 7Department of Biochemistry and Cancer Center, University of Puerto Rico, Medical Science Campus, San Juan, Puerto Rico; Authors' Affiliations: Departments of 1Obstetrics and Gynecology and 2Med/Hematology & Med Oncology and CTRC at The UT Health Science Center, San Antonio; Departments of 3Experimental Therapeutics, 4Gynecologic Oncology, 5Cancer Biology, and 6Center for RNA interference and non-coding RNA, University of Texas MD Anderson Cancer Center, Houston, Texas; and 7Department of Biochemistry and Cancer Center, University of Puerto Rico, Medical Science Campus, San Juan, Puerto Rico 10Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.; 11Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. 2Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 6Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 11Center for RNAi and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas. MD Anderson Cancer Center, Department of Gynecologic Oncology & Reproductive Medicine, USA Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Cancer Biology, and 3Experimental Therapeutics, and 4Center for RNA Interference and Non-coding RNA, University of Texas MD Anderson Cancer Center, Houston, Texas; 5Department of Medicine, Division of Hematology–Oncology, UCLA School of Medicine, Los Angeles, California; 6Departments of Psychology and Gynecology and the Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa; 7School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin; 8Radiation Biophysics Laboratory, NASA Johnson Space Center, University of Space Research Association, Houston, Texas, and 9Institute for Clinical and Translational Science General Hospital-Boyd Tower, Iowa City, Iowa; Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Cancer Biology, and 3Experimental Therapeutics, and 4Center for RNA Interference and Non-coding RNA, University of Texas MD Anderson Cancer Center, Houston, Texas; 5Department of Medicine, Division of Hematology–Oncology, UCLA School of Medicine, Los Angeles, California; 6Departments of Psychology and Gynecology and the Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa; 7School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin; 8Radiation Biophysics Laboratory, NASA Johnson Space Center, University of Space Research Association, Houston, Texas, and 9Institute for Clinical and Translational Science General Hospital-Boyd Tower, Iowa City, Iowa; Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Cancer Biology, and 3Experimental Therapeutics, and 4Center for RNA Interference and Non-coding RNA, University of Texas MD Anderson Cancer Center, Houston, Texas; 5Department of Medicine, Division of Hematology–Oncology, UCLA School of Medicine, Los Angeles, California; 6Departments of Psychology and Gynecology and the Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa; 7School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin; 8Radiation Biophysics Laboratory, NASA Johnson Space Center, University of Space Research Association, Houston, Texas, and 9Institute for Clinical and Translational Science General Hospital-Boyd Tower, Iowa City, Iowa Authors' Affiliations: Departments of 1Gynecologic Oncology and 2Cancer Biology, and 3Center for RNAi and Non-Coding RNA, M.D. Anderson Cancer Center, and 4Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Baylor College of Medicine, Houston, Texas; and 5Cancer Research, GlaxoSmithKline, Collegeville, Pennsylvania; Authors' Affiliations: Departments of 1Gynecologic Oncology and 2Cancer Biology, and 3Center for RNAi and Non-Coding RNA, M.D. Anderson Cancer Center, and 4Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Baylor College of Medicine, Houston, Texas; and 5Cancer Research, GlaxoSmithKline, Collegeville, Pennsylvania; Authors' Affiliations: Departments of 1Gynecologic Oncology and 2Cancer Biology, and 3Center for RNAi and Non-Coding RNA, M.D. Anderson Cancer Center, and 4Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Baylor College of Medicine, Houston, Texas; and 5Cancer Research, GlaxoSmithKline, Collegeville, Pennsylvania University of Texas MD Anderson Cancer Center, Department of Gynecologic Oncology and Reproductive Medicine, 1515 Holcombe Boulevard, Houston, Texas 77030, United StatesfUniversity of Texas MD Anderson Cancer Center, Center for RNA Interference and Non-Co 1Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 3Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 4Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Gynecologic Oncology and Reproductive Medicine The University of Texas MD Anderson Cancer Center Houston Texas; Center for RNA Interference and Non‐Coding RNA The University of Texas MD Anderson Cancer Center Houston Texas Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for RNAi and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 3Department of Gynecologic Oncology, and Center for RNA Interference and Non-Coding RNA, University of Texas MD Anderson Cancer Center, Houston, Texas. Departments of Gynecologic Oncology and Cancer Biology, and Center for RNA Interference and Non-Coding RNA, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030; and 3Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Experimental Therapeutics, and 3Cancer Biology; and 4Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Experimental Therapeutics, and 3Cancer Biology; and 4Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Experimental Therapeutics, and 3Cancer Biology; and 4Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Cancer Biology, and 3Experimental Therapeutics; 4Center for RNA Interference and Non-Coding RNA, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 5Department of Pathology and 6Medicine, University of Southern California; and 7Vasgene Therapeutics, Los Angeles, California; Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Cancer Biology, and 3Experimental Therapeutics; 4Center for RNA Interference and Non-Coding RNA, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 5Department of Pathology and 6Medicine, University of Southern California; and 7Vasgene Therapeutics, Los Angeles, California; Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Cancer Biology, and 3Experimental Therapeutics; 4Center for RNA Interference and Non-Coding RNA, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 5Department of Pathology and 6Medicine, University of Southern California; and 7Vasgene Therapeutics, Los Angeles, California Amal Melhem-Bertrandt, Mariana Chavez-MacGregor, Xiudong Lei, Erika N. Brown, Richard T. Lee, Funda Meric-Bernstam, Anil K. Sood, Gabriel N. Hortobagyi, Ana-Maria Gonzalez-Angulo, The University of Texas MD Anderson Cancer Center, Houston, TX; and Suzanne D. Conzen, the University of Chicago, Chicago, IL. 2Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, Texas.; 3Center for RNA Interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas. Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center (MDACC), 1515 Holcombe Blvd., Houston, TX, 77030, USA. Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, USA. 1Departments of Gynecologic Oncology and Reproductive Medicine,; 7Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 8Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 3Center for RNA Interference and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 6Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Gynecologic Oncology and Reproductive Medicine The University of Texas MD Anderson Cancer Center Houston Texas; Center for RNAi and Non-Coding RNAs The University of Texas MD Anderson Cancer Center Houston Texas Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Systems Biology, and 3Cancer Biology, MD Anderson Cancer Center, and 4Center for RNA Interference and Non-Coding RNA, University of Texas, Houston, Texas; 5Department of Obstetrics and Gynecology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California; 6Department of Obstetrics and Gynecology, University of Tokushima, Tokushima, Japan; 7Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; 8The Gynecologic Oncology Center, Mercy Medical Center, Baltimore, Maryland; 9Department of Obstetrics and Gynecology, Kitano Hospital;10Department of Obstetrics and Gynecology, Osaka Rosai Hospital; and 11Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan; Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Systems Biology, and 3Cancer Biology, MD Anderson Cancer Center, and 4Center for RNA Interference and Non-Coding RNA, University of Texas, Houston, Texas; 5Department of Obstetrics and Gynecology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California; 6Department of Obstetrics and Gynecology, University of Tokushima, Tokushima, Japan; 7Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; 8The Gynecologic Oncology Center, Mercy Medical Center, Baltimore, Maryland; 9Department of Obstetrics and Gynecology, Kitano Hospital;10Department of Obstetrics and Gynecology, Osaka Rosai Hospital; and 11Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan; Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Systems Biology, and 3Cancer Biology, MD Anderson Cancer Center, and 4Center for RNA Interference and Non-Coding RNA, University of Texas, Houston, Texas; 5Department of Obstetrics and Gynecology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California; 6Department of Obstetrics and Gynecology, University of Tokushima, Tokushima, Japan; 7Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; 8The Gynecologic Oncology Center, Mercy Medical Center, Baltimore, Maryland; 9Department of Obstetrics and Gynecology, Kitano Hospital;10Department of Obstetrics and Gynecology, Osaka Rosai Hospital; and 11Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Osaka, Japan 6Gynecologic Oncology and; 7Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 3Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 4Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. From the Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Departments of Biostatistics, Psychology, Urology, and Microbiology, and the Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA; Department of Gynecologic Oncology, University of Texas M.D. Anderson Comprehensive Cancer Center, Houston, TX; and Department of Obstetrics and Gynecology, Hartford Hospital, Hartford, CT Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Genitourinary Medical Oncology, 3Bioinformatics and Computational Biology, and 4Cancer Biology; 5Division of Cancer Medicine; 6Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; 7Kinex Pharmaceuticals LLC, New York State Center of Excellence in Bioinformatics and Life Sciences, Buffalo, New York; 8Department of General Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei; 9Department of Gynecology, Obstetrics and Gynecology, Hospital of Fudan University, Shanghai, P.R. China; Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Genitourinary Medical Oncology, 3Bioinformatics and Computational Biology, and 4Cancer Biology; 5Division of Cancer Medicine; 6Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; 7Kinex Pharmaceuticals LLC, New York State Center of Excellence in Bioinformatics and Life Sciences, Buffalo, New York; 8Department of General Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei; 9Department of Gynecology, Obstetrics and Gynecology, Hospital of Fudan University, Shanghai, P.R. China; Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Genitourinary Medical Oncology, 3Bioinformatics and Computational Biology, and 4Cancer Biology; 5Division of Cancer Medicine; 6Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; 7Kinex Pharmaceuticals LLC, New York State Center of Excellence in Bioinformatics and Life Sciences, Buffalo, New York; 8Department of General Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei; 9Department of Gynecology, Obstetrics and Gynecology, Hospital of Fudan University, Shanghai, P.R. China 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 6Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 7Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas. Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 5Department of Gynecologic Oncology and Reproductive Medicine, University of Texas, MD Anderson Cancer Center, Houston, Texas.; 7Center for RNA Interference and Non-Coding RNA Cancer, University of Texas, MD Anderson Cancer Center, Houston, Texas. Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;; Center for RNA Interference and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Authors' Affiliations: 1University of Texas M.D. Anderson Cancer Center, Houston, Texas; 2Vanderbilt University Medical Center, Nashville, Tennessee; 3IDDI Corp., Houston, Texas; 4University of Texas Medical Branch at Galveston, Galveston, Texas; 5Moffitt Cancer Center, Tampa, Florida; 6University of Arkansas for Medical Sciences, Little Rock, Arkansas; 7St. Luke's Roosevelt Hospital Center, New York, New York; and 8University of Iowa, Iowa City, Iowa Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030;; Department of Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; 1Department of Gynecologic Oncology,; 3Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center; 2Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 4Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 6Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 1Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas. Authors' Affiliations: 1Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center at Houston; Departments of 2Gynecologic Oncology, 3Cancer Biology, 4Experimental Therapeutics, and 5Surgical Oncology, and 6Center for RNA Interference and Non-Coding RNA, University of Texas M.D. Anderson Cancer Center; 7Department of Bioengineering, Rice University; and 8Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas; 9Department of Biomedical Engineering, University of Texas Austin, Austin, Texas; and 10Department of Surgery and 11The University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico; Authors' Affiliations: 1Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center at Houston; Departments of 2Gynecologic Oncology, 3Cancer Biology, 4Experimental Therapeutics, and 5Surgical Oncology, and 6Center for RNA Interference and Non-Coding RNA, University of Texas M.D. Anderson Cancer Center; 7Department of Bioengineering, Rice University; and 8Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas; 9Department of Biomedical Engineering, University of Texas Austin, Austin, Texas; and 10Department of Surgery and 11The University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico; Authors' Affiliations: 1Department of Nanomedicine and Biomedical Engineering, University of Texas Health Science Center at Houston; Departments of 2Gynecologic Oncology, 3Cancer Biology, 4Experimental Therapeutics, and 5Surgical Oncology, and 6Center for RNA Interference and Non-Coding RNA, University of Texas M.D. Anderson Cancer Center; 7Department of Bioengineering, Rice University; and 8Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas; 9Department of Biomedical Engineering, University of Texas Austin, Austin, Texas; and 10Department of Surgery and 11The University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico Department of Gynecologic Oncology, U.T. M.D. Anderson Cancer Center, Unit 1362, P.O. Box 301439, Houston TX 77230-1439, USA; Department of Cancer Biology, U.T. M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 173, Houston TX 77030, USA 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 6Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 7Center for RNA Interference and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Gynecologic Oncology and Reproductive Medicine University of Texas MD Anderson Cancer Center Houston TX USA; Department of Cancer Biology University of Texas MD Anderson Cancer Center Houston TX USA; Center for RNAi and Non‐Coding RNA University of Texas MD Anderson Cancer Center Houston TX USA Department of Gynecological Oncology, MD Anderson Cancer Center, Houston, TX 77030 From the Departments of Psychology, Obstetrics and Gynecology, Urology, and Microbiology; Holden Comprehensive Cancer Center, University of Iowa, Iowa City; Department of Veterans Affairs Medical Center, Iowa City; Institute for Social Science Research, Iowa State University, Ames, Iowa; Department of Psychology; Division of Gynecologic Oncology; Sylvester Comprehensive Cancer Center, University of Miami; Department of Psychology, University of Wisconsin, Madison; Department of Psychological and Brain... 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 4Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 8Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston Department of Gynecologic Oncology, M.D. Anderson Cancer Center, Houston, TX, USA; Department of Cancer Biology, M.D. Anderson Cancer Center, Houston, TX, USA; Center for RNA Interference and Non-Coding RNA, M.D. Anderson Cancer Center, Houston, TX, USA 4Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA 1Gynecologic Oncology, Departments of; 3Cancer Biology, The University of Texas M. D. Anderson Cancer Center; Departments of Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 4Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 5Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas MD Anderson Cancer Center, Houston, TX. 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.; 3Department of Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.; 4Center for RNA Interference and Non-Coding RNA, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Department of Gynecologic Oncology & Reproductive Medicine, Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas. 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Authors' Affiliations: 1Department of Gynecologic Oncology, 2Department of Cancer Biology, and 3Center for RNA Interference and Non-Coding RNA, University of Texas M.D. Anderson Cancer Center; 4Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas; 5Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine; 6Department of Obstetrics and Gynecology, Konkuk University Hospital, Konkuk University School of Medicine; 7Department of Obstetrics and Gynecology, Yonsei University College of Medicine; 8Department of Pathology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, Seoul, South Korea; 9Department of Obstetrics and Gynecology, Dongguk University Ilsan Hospital, Goyang, South Korea; and 10Medimmune, LLC, Gaithersburg, Maryland; Authors' Affiliations: 1Department of Gynecologic Oncology, 2Department of Cancer Biology, and 3Center for RNA Interference and Non-Coding RNA, University of Texas M.D. Anderson Cancer Center; 4Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas; 5Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine; 6Department of Obstetrics and Gynecology, Konkuk University Hospital, Konkuk University School of Medicine; 7Department of Obstetrics and Gynecology, Yonsei University College of Medicine; 8Department of Pathology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, Seoul, South Korea; 9Department of Obstetrics and Gynecology, Dongguk University Ilsan Hospital, Goyang, South Korea; and 10Medimmune, LLC, Gaithersburg, Maryland; Authors' Affiliations: 1Department of Gynecologic Oncology, 2Department of Cancer Biology, and 3Center for RNA Interference and Non-Coding RNA, University of Texas M.D. Anderson Cancer Center; 4Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas; 5Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine; 6Department of Obstetrics and Gynecology, Konkuk University Hospital, Konkuk University School of Medicine; 7Department of Obstetrics and Gynecology, Yonsei University College of Medicine; 8Department of Pathology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, Seoul, South Korea; 9Department of Obstetrics and Gynecology, Dongguk University Ilsan Hospital, Goyang, South Korea; and 10Medimmune, LLC, Gaithersburg, Maryland Department of Gynecologic Oncology and Reproductive Medicine UT MD Anderson Cancer Center Houston Texas USA 1Gynecologic Oncology, Departments of; 3Cancer Biology, University of Texas M. D. Anderson Cancer Center; and Center for RNA Interference and Non-Coding RNAs, MDACC, Houston, TX, USA. Department of Cancer Biology, MDACC, Houston, TX, USA. 4Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Center for RNA interference and Non‐Coding RNA MD Anderson Cancer Center Houston TX USA abv MD Anderson Cancer Center , Department of Cancer Biology , Houston , TX , USA. abx MD Anderson Cancer Center , Department of Gynecologic Oncology and Reproductive Medicine , Houston , TX , USA. 5Department of Gynecologic Oncology and; 6Center for RNA Interference and Non-coding RNA; Department of Gynecologic Oncology MD Anderson Cancer Center Houston TX Susan K. Lutgendorf, Koen De Geest, David Bender, Amina Ahmed, Michael J. Goodheart, Laila Dahmoush, M. Bridget Zimmerman, and David M. Lubaroff, University of Iowa; Susan K. Lutgendorf and David M. Lubaroff, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA; Frank J. Penedo, Joseph A. Lucci III, and Parvin Ganjei-Azar, Sylvester Comprehensive Cancer Center, University of Miami, Coral Gables, FL; Premal H. Thaker, Washington University School of Medicine, St Louis, MO; Luis Mendez,... Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 2Center for RNA Interference and Non-Coding RNA, University of Texas, M.D. Anderson Cancer Center, Houston, Texas.; 3Department of Gynecologic Oncology and Reproductive Medicine, University of Texas, M.D. Anderson Cancer Center, Houston, Texas. Department of Gynecologic Oncology and Reproductive Medicine, UT MD Anderson Comprehensive Cancer Center, Houston, Texas, USA; Department of Cancer Biology, and Center for RNA Interference and Noncoding RNA, UT MD Anderson Comprehensive Cancer Center, Houston, Texas, USA Departments of Gynecologic Oncology and Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030 and 6Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, Texas. Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA 1Gynecologic Oncology and Departments of; 2Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas; Ovarian Cancer Action Research Center, Department of Surgery and Cancer Imperial College London London United Kingdom The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA Departments of Gynecologic Oncology Cancer Biology and Center for RNA Interference and Noncoding RNA UT MD Anderson Cancer Center Houston Texas USA 5Department of Gynecologic Oncology, M.D. Anderson Cancer Center, Houston, Texas 1Gynecologic Oncology and Departments of; 2Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Department of Gynecologic Oncology and Reproductive Medicine The University of Texas MD Anderson Cancer Center Houston Texas; Department of Cancer Biology The University of Texas MD Anderson Cancer Center Houston Texas; Center for RNA Interference and Non‐Coding RNA Program, Department of Experimental Therapeutics The University of Texas MD Anderson Cancer Center Houston Texas Department of Gynecologic Oncology and Reproductive Medicine, and the Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX Department of Center for RNAi and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 2Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 3Center for RNAi and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 8Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, Texas, USA; Center for RNA Interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas, USA; Department of Cancer Biology, MD Anderson Cancer Center, Houston, Texas, USA Authors' Affiliations: 1Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama; 2Department of Gynecologic Oncology, U.T.M.D. Anderson Cancer Center, Houston, Texas; 3Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina; 4Department of Experimental Therapeutics, U.T.M.D. Anderson Cancer Center, Houston, Texas; 5The University of Puerto Rico Comprehensive Cancer Center, Rio Piedras, PR; and 6Center for RNA Interference and Non-Coding RNA; 7Department of Cancer Biology, U.T.M.D. Anderson Cancer Center, Houston, Texas; Authors' Affiliations: 1Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama; 2Department of Gynecologic Oncology, U.T.M.D. Anderson Cancer Center, Houston, Texas; 3Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina; 4Department of Experimental Therapeutics, U.T.M.D. Anderson Cancer Center, Houston, Texas; 5The University of Puerto Rico Comprehensive Cancer Center, Rio Piedras, PR; and 6Center for RNA Interference and Non-Coding RNA; 7Department of Cancer Biology, U.T.M.D. Anderson Cancer Center, Houston, Texas; Authors' Affiliations: 1Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama; 2Department of Gynecologic Oncology, U.T.M.D. Anderson Cancer Center, Houston, Texas; 3Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina; 4Department of Experimental Therapeutics, U.T.M.D. Anderson Cancer Center, Houston, Texas; 5The University of Puerto Rico Comprehensive Cancer Center, Rio Piedras, PR; and 6Center for RNA Interference and Non-Coding RNA; 7Department of Cancer Biology, U.T.M.D. Anderson Cancer Center, Houston, Texas Department of Gynecologic Oncology and Cancer Biology, M.D. Anderson Cancer Center, Houston, TX, USA; Center for RNA Interference and Non-Coding RNA, M.D. Anderson Cancer Center, Houston, TX, USA Department of Obstetrics and Gynecology, University of Florida College of Medicine, P.O. Box 100294, Gainesville, FL 32610-0294, USA The University of Texas MD Anderson Cancer Center, Houston, TX 1Gynecologic Oncology, Departments of; 2Cancer Biology, 4Center for RNA Interference and Non-coding RNA, University of Texas MD Anderson Cancer Center, Houston, Texas.; 5Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas. 1Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 5Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 6Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas. 1Cancer Biology and Departments of; 2Gynecologic Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, USA. [email protected]. Center for RNA Interference and Non-Coding RNA, MDACC, Houston, TX, USA. [email protected]. Department of Cancer Biology, MDACC, Houston, TX, USA. [email protected]. From the Washington University School of Medicine, St Louis, MO; Gynecologic Oncology Group Statistical and Data Cancer; Roswell Park Cancer Institute, Buffalo, NY; Department of Gynecologic Oncology, University of Pennsylvania Cancer Center, Philadelphia, PA; Division of Gynecologic Oncology, University of Iowa Hospitals and Clinics, Iowa City, IA; and Division of Gynecologic Oncology, University of Connecticut School of Medicine, Farmington, CT. Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX; and 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 3Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 7Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Gynecologic Oncology and Reproductive Medicine and Department of Gynecologic Oncology The University of Texas MD Anderson Cancer Center Houston Texas; Department of Cancer Biology The University of Texas MD Anderson Cancer Center Houston Texas Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, 77054, USA. [email protected]. Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, 77054, USA. [email protected]. Department of Cancer Biology, The University of Texas MDAnderson Cancer Center (MDACC), Houston, TX, 77054, USA. [email protected]. 7Departments of Gynecologic Oncology and Cell Biology, University of Texas MD Anderson Cancer Center, Houston Texas. University of Texas, MD Anderson Cancer Center, Houston Departments of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA.; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA.; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA. Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA From the Division of Gynecologic Oncology, Ellis Fischel Cancer Center, University of Missouri Health Sciences Center, Columbia; Department of Obstetrics and Gynecology, Division Gynecologic Oncology, Washington University School of Medicine, St Louis, MO; Gynecologic Oncology Group, Roswell Park Cancer Institute, Buffalo, NY; Columbus Oncology Associates, Columbus; The Cleveland Clinic Taussig Cancer Center, Department of Hematology/Medical Oncology, The Cleveland Clinic Foundation, Cleveland, OH;... Depatment of Gynecologic Oncology and Reproductive Medicine The University of Texas MD Anderson Cancer Center Houston TX 77030 USA; Center for RNAi and Non‐Coding RNA The University of Texas MD Anderson Cancer Center Houston TX 77030 USA 4Gynecologic Oncology, Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Experimental Therapeutics, 3Cancer Biology, and 4Thoracic, Head & Neck Medical Oncology, 5Graduate School of Biomedical Sciences, 6The Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas; 7Division of Gynecologic Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; 8Department of Obstetrics and Gynecology, The University of Tokushima, Graduate School, Tokushima, Japan; 9Department of Surgery, School of Medicine, Gyeongsang National University, Jin-ju, South Korea; and 10Bioinformatics Core Facility, Swiss Institute of Bioinformatics, Batiment Genopode, Lausanne, Switzerland; Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Experimental Therapeutics, 3Cancer Biology, and 4Thoracic, Head & Neck Medical Oncology, 5Graduate School of Biomedical Sciences, 6The Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas; 7Division of Gynecologic Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; 8Department of Obstetrics and Gynecology, The University of Tokushima, Graduate School, Tokushima, Japan; 9Department of Surgery, School of Medicine, Gyeongsang National University, Jin-ju, South Korea; and 10Bioinformatics Core Facility, Swiss Institute of Bioinformatics, Batiment Genopode, Lausanne, Switzerland; Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Experimental Therapeutics, 3Cancer Biology, and 4Thoracic, Head & Neck Medical Oncology, 5Graduate School of Biomedical Sciences, 6The Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas; 7Division of Gynecologic Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; 8Department of Obstetrics and Gynecology, The University of Tokushima, Graduate School, Tokushima, Japan; 9Department of Surgery, School of Medicine, Gyeongsang National University, Jin-ju, South Korea; and 10Bioinformatics Core Facility, Swiss Institute of Bioinformatics, Batiment Genopode, Lausanne, Switzerland 3Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 4Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Department of Pathology, Department of Anatomy and Cell Biology, and Holden Comprehensive Cancer Center at the University of Iowa, University of Iowa Hospitals and Clinics, Iowa City, Iowa Authors' Affiliations: Departments of 1Bioinformatics and Computational Biology, 2Gynecologic Oncology and Reproductive Medicine, 3Experimental Therapeutics, 4Cancer Biology, and 5Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and 6Fred Hutchinson Cancer Research Center, Seattle, Washington; Authors' Affiliations: Departments of 1Bioinformatics and Computational Biology, 2Gynecologic Oncology and Reproductive Medicine, 3Experimental Therapeutics, 4Cancer Biology, and 5Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and 6Fred Hutchinson Cancer Research Center, Seattle, Washington; Authors' Affiliations: Departments of 1Bioinformatics and Computational Biology, 2Gynecologic Oncology and Reproductive Medicine, 3Experimental Therapeutics, 4Cancer Biology, and 5Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and 6Fred Hutchinson Cancer Research Center, Seattle, Washington Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, 1155 Herman Pressler Drive CPB6.3244, Houston, TX 77030–3721, USA Department of Gynecologic and Reproductive Oncology and the Center for RNAi and Non‐Coding RNA,The University of Texas MD Anderson Cancer Center,Houston,TX 1Gynecologic Oncology, Departments of; 4Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas and Department of Gynecologic Oncology and Reproductive Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, USA Department of Gynecologic Oncology and Reproductive Medicine, the University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNA, the University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, the University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Surgical Oncology, 3Experimental Therapeutics, and 4Cancer Biology, and 5Center for RNA Interference and Non-coding RNA, The University of Texas M.D. Anderson Cancer Center, and 6Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas; 7Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 8Department of Pathology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, 9Women's Cancer Clinic, Department of Obstetrics and Gynecology, Yonsei University College of Medicine, and 10Department of Obstetrics and Gynecology, Konkuk University Hospital, Konkuk University School of Medicine, Seoul, Korea; 11Department of Surgery, School of Medicine, University of Puerto Rico, and 12University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico; and 13Department of Obstetrics & Gynecology, Dongguk University IIsan Hospital,; Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Surgical Oncology, 3Experimental Therapeutics, and 4Cancer Biology, and 5Center for RNA Interference and Non-coding RNA, The University of Texas M.D. Anderson Cancer Center, and 6Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas; 7Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 8Department of Pathology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, 9Women's Cancer Clinic, Department of Obstetrics and Gynecology, Yonsei University College of Medicine, and 10Department of Obstetrics and Gynecology, Konkuk University Hospital, Konkuk University School of Medicine, Seoul, Korea; 11Department of Surgery, School of Medicine, University of Puerto Rico, and 12University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico; and 13Department of Obstetrics & Gynecology, Dongguk University IIsan Hospital,; Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Surgical Oncology, 3Experimental Therapeutics, and 4Cancer Biology, and 5Center for RNA Interference and Non-coding RNA, The University of Texas M.D. Anderson Cancer Center, and 6Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas; 7Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 8Department of Pathology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, 9Women's Cancer Clinic, Department of Obstetrics and Gynecology, Yonsei University College of Medicine, and 10Department of Obstetrics and Gynecology, Konkuk University Hospital, Konkuk University School of Medicine, Seoul, Korea; 11Department of Surgery, School of Medicine, University of Puerto Rico, and 12University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico; and 13Department of Obstetrics & Gynecology, Dongguk University IIsan Hospital, 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 5Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 6Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 1Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 4Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 5Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 1Gynecologic Oncology and Departments of; 2Cancer Biology, The University of Texas M. D. Anderson Cancer Center; Departments of Gynecologic Oncology, Cancer Biology, and Center for RNA Interference and Noncoding RNA, University of Texas, M.D. Anderson Cancer Center 2Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 3Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 6Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Authors' Affiliations: 1Division of Hematology-Oncology, Department of Medicine, UCLA School of Medicine, 2Jonsson Comprehensive Cancer Center, 3Norman Cousins Center and 4UCLA Molecular Biology Institute, Los Angeles, California; Departments of 5Gynecologic Oncology and 6Cancer Biology, and 7Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; Authors' Affiliations: 1Division of Hematology-Oncology, Department of Medicine, UCLA School of Medicine, 2Jonsson Comprehensive Cancer Center, 3Norman Cousins Center and 4UCLA Molecular Biology Institute, Los Angeles, California; Departments of 5Gynecologic Oncology and 6Cancer Biology, and 7Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; Authors' Affiliations: 1Division of Hematology-Oncology, Department of Medicine, UCLA School of Medicine, 2Jonsson Comprehensive Cancer Center, 3Norman Cousins Center and 4UCLA Molecular Biology Institute, Los Angeles, California; Departments of 5Gynecologic Oncology and 6Cancer Biology, and 7Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Gynecologic Oncology, MD Anderson Cancer Center University of Texas Houston TX; Cancer Biology, MD Anderson Cancer Center University of Texas Houston TX; Center for RNA Interference and Non‐Coding RNA University of Texas Houston TX Authors' Affiliations: 1Department of Gynecologic Oncology, M.D. Anderson Cancer Center, 2Department of Cancer Biology, M.D. Anderson Cancer Center, and 3Center for RNAi and Non-Coding RNA, M.D. Anderson Cancer Center, Houston, Texas; Authors' Affiliations: 1Department of Gynecologic Oncology, M.D. Anderson Cancer Center, 2Department of Cancer Biology, M.D. Anderson Cancer Center, and 3Center for RNAi and Non-Coding RNA, M.D. Anderson Cancer Center, Houston, Texas; Authors' Affiliations: 1Department of Gynecologic Oncology, M.D. Anderson Cancer Center, 2Department of Cancer Biology, M.D. Anderson Cancer Center, and 3Center for RNAi and Non-Coding RNA, M.D. Anderson Cancer Center, Houston, Texas Center for RNA Interference and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. [email protected]. Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Bldg., CPB6.3275, 1515 Holcombe Blvd., Unit 1362, Houston, TX, 77030, USA. [email protected]. Program in Cancer Biology and Cancer Metastasis, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX, USA. [email protected]. Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. [email protected]. 2Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Departments of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Center for RNA Interference and Non-Coding RNA, The University of Texas M.D. Anderson Cancer Center, Houston, TX Departments of Gynecologic Oncology, Cancer Biology and Center for RNA Interference and Noncoding RNA, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77230, United States; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas 77054, United States 1Cancer Biology, Departments of; 3Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 1Gynecologic Oncology and Departments of; 2Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; Department of Cancer Biology, UTMD Anderson Cancer Center, TX, USA. 5Department of Gynecologic Oncology and Reproductive Medicine, and the Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas. Gyneclogic Oncology, Cancer Biology, and Center for RNA Interference and Noncoding RNA The University of Texas MD Anderson Cancer Center Houston Texas Departments of Gynecologic Oncology and Reproductive Medicine and Cancer Biology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA; Center for RNA Interference and Non-Coding RNAs, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030;; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030;; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 Authors' Affiliations: 1Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama; and Departments of 2Gynecologic Oncology, 3Experimental Therapeutics, and 4Cancer Biology, and 5Center for RNA Interference and Non-Coding RNA, U.T.M.D. Anderson Cancer Center, Houston, Texas; Authors' Affiliations: 1Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama; and Departments of 2Gynecologic Oncology, 3Experimental Therapeutics, and 4Cancer Biology, and 5Center for RNA Interference and Non-Coding RNA, U.T.M.D. Anderson Cancer Center, Houston, Texas; Authors' Affiliations: 1Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, Alabama; and Departments of 2Gynecologic Oncology, 3Experimental Therapeutics, and 4Cancer Biology, and 5Center for RNA Interference and Non-Coding RNA, U.T.M.D. Anderson Cancer Center, Houston, Texas Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA 3Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 4Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 7Center for RNAi and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas. Affiliations of authors: Department of Gynecologic Oncology and Reproductive Medicine (RAP, HJD, RR, JMH, YL, JH, MH, MJW, KMG, ASN, JF, MHM, KN, PLD, SLL, LSM, SP, SYW, AKS), Department of Cancer Biology (AKS), and Center for RNA Interference and Non-Coding RNAs (CI, LSM, AKS), The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Basic Sciences, Division of Pharmacology, Ponce Health Sciences U Authors' Affiliations: 1University of Puerto Rico Comprehensive Cancer Center; 2Department of Biochemistry, University of Puerto Rico, Medical Science Campus, San Juan, Puerto Rico; Departments of 3Experimental Therapeutics, 4Gynecologic Oncology, and 5Cancer Biology, 6Center for RNA Interference and Non-Coding RNA, University of Texas MD Anderson Cancer Center, Houston, Texas; 7Centro de Investigación y de Estudios Avanzados del IPN; 8Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies, National Polytechnic Institute, México, D.F. México; and 9School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin; Authors' Affiliations: 1University of Puerto Rico Comprehensive Cancer Center; 2Department of Biochemistry, University of Puerto Rico, Medical Science Campus, San Juan, Puerto Rico; Departments of 3Experimental Therapeutics, 4Gynecologic Oncology, and 5Cancer Biology, 6Center for RNA Interference and Non-Coding RNA, University of Texas MD Anderson Cancer Center, Houston, Texas; 7Centro de Investigación y de Estudios Avanzados del IPN; 8Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies, National Polytechnic Institute, México, D.F. México; and 9School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Iowa Hospitals and Clinics 2Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, Texas.; 5Center for RNA Interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas. 6Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 7Center for RNAi and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 8Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA; Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA; Center for RNAi and non-coding RNA, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA Department of Cancer Biology & Center for RNAi & Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 3Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 5Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Authors' Affiliations: 1Department of Biomedical Sciences, Cornell University, Ithaca, New York; 2Institute of Pathology, Ruhr-University-Bochum, Bochum, Germany; 3Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania; 4Departments of Gynecologic Oncology and Cancer Biology, and Center for RNA Interference and Non-Coding RNA, M.D. Anderson Cancer Center, Houston, Texas; 5Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, New York; and 6Experimental and Molecular Pathology, Institute of Pathology, Ludwig-Maximilians-University Munich, Munich, Germany 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 4Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 6Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas. 1Gynecologic Oncology, Departments of; 4Cancer Biology, The University of Texas M. D. Anderson Cancer Center, and 1Gynecologic Oncology, Departments of; 3Cancer Biology, The University of Texas M.D. Anderson Cancer Center; 1Gynecologic Oncology, and Departments of Department of Gynecologic Oncology and Reproductive Medicine The University of Texas MD Anderson Cancer Center Houston Texas Department of Gynecologic Oncology and Reproductive Medicine,The University of Texas MD Anderson Cancer Center,Houston,TX; Center for RNA Interference and Non‐Coding RNA,The University of Texas MD Anderson Cancer Center,Houston,TX; Department of Cancer Biology,The University of Texas MD Anderson Cancer Center,Houston,TX Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for RNA Interference and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 4Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 5Center for RNAi and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 11Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Authors' Affiliations: 1Department of Gynecologic Oncology, 2Center for RNA Interference and Non-Coding RNA, and 3Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Authors' Affiliations: 1Department of Gynecologic Oncology, 2Center for RNA Interference and Non-Coding RNA, and 3Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Authors' Affiliations: 1Department of Gynecologic Oncology, 2Center for RNA Interference and Non-Coding RNA, and 3Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas Authors' Affiliations: Departments of 1Breast Medical Oncology, 2Gynecologic Oncology and Reproductive Medicine, 3Cancer Biology, and 4Center for RNA Interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas; Authors' Affiliations: Departments of 1Breast Medical Oncology, 2Gynecologic Oncology and Reproductive Medicine, 3Cancer Biology, and 4Center for RNA Interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas; Authors' Affiliations: Departments of 1Breast Medical Oncology, 2Gynecologic Oncology and Reproductive Medicine, 3Cancer Biology, and 4Center for RNA Interference and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas Department of Gynecologic Oncology and Reproductive Medicine and; Department of Cancer Biology and; Center for RNA Interference and Non-Coding RNA, University of Texas MD Anderson Cancer Center, Houston, TX Authors' Affiliations: 1UCLA Norman Cousins Center at the Semel Institute for Neuroscience and Human Behavior, Department of Medicine, 2Division of Hematology-Oncology, UCLA School of Medicine, UCLA AIDS Institute, 3Jonsson Comprehensive Cancer Center, 4UCLA Department of Molecular and Medical Pharmacology, and 5UCLA Molecular Biology Institute, Los Angeles, California; and 6Departments of Gynecologic Oncology and Cancer Biology, M.D. Anderson Comprehensive Cancer Center, Houston, Texas From the Department of Gynecologic Oncology and the Department of Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX; and the Center for Cancer Research, National Cancer Institute, Bethesda, MD Department of Gynecologic Oncology and Reproductive Medicine The University of Texas MD Anderson Cancer Center Houston TX 77030 USA; Center for RNAi and Non‐Coding RNA The University of Texas MD Anderson Cancer Center Houston TX 77030 USA 1Gynecologic Oncology, Departments of; 4Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; Department of Gynecologic Oncology The University of Texas MD Anderson Cancer Center Houston Texas; Department of Cancer Biology The University of Texas MD Anderson Cancer Center Houston Texas; Center for RNA Interference and Noncoding RNA The University of Texas MD Anderson Cancer Center Houston Texas 1Gynecologic Oncology and Departments of; 3Department of Psychology, University of Iowa, Iowa City, Iowa: and Authors' Affiliations: 1Division of Cancer Medicine, Departments of 2Gynecologic Oncology, 3Gastrointestinal Medical Oncology, 4Pathology, 5Surgical Oncology, 6Cancer Biology, 7Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; 8Biocept Inc., San Diego, California; and 9Department of Obstetrics and Gynecology, Dongguk University Ilsan Hospital, Goyang, Korea; Authors' Affiliations: 1Division of Cancer Medicine, Departments of 2Gynecologic Oncology, 3Gastrointestinal Medical Oncology, 4Pathology, 5Surgical Oncology, 6Cancer Biology, 7Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; 8Biocept Inc., San Diego, California; and 9Department of Obstetrics and Gynecology, Dongguk University Ilsan Hospital, Goyang, Korea; Authors' Affiliations: 1Division of Cancer Medicine, Departments of 2Gynecologic Oncology, 3Gastrointestinal Medical Oncology, 4Pathology, 5Surgical Oncology, 6Cancer Biology, 7Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; 8Biocept Inc., San Diego, California; and 9Department of Obstetrics and Gynecology, Dongguk University Ilsan Hospital, Goyang, Korea Gynecologic Oncology and Reproductive Medicine, Cell Biology, and; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; and 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.; 10Center for RNA Interference and Non-coding RNA, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.; 16Department of Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. 1Department of Gynecologic Oncology, University of Texas, M. D. Anderson Cancer Center, Houston, Texas; 7Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 8Center for RNA Interference and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 9Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. 1Gynecologic Oncology, Departments of; 3Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, Texas; Authors' Affiliations: 1Department of Nanomedicine, The Methodist Hospital Research Institute; 2Departments of Experimental Therapeutics, 3Gynecologic Oncology, and 4Cancer Biology, 5Center for RNA Interference and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; Departments of 6Cell and Developmental Biology and 7Medicine, Weill Cornell Medical College, New York, New York; and 8Centro de Investigación y de Estudios Avanzados del IPN, Unidad Monterrey, Apodaca, México; Authors' Affiliations: 1Department of Nanomedicine, The Methodist Hospital Research Institute; 2Departments of Experimental Therapeutics, 3Gynecologic Oncology, and 4Cancer Biology, 5Center for RNA Interference and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; Departments of 6Cell and Developmental Biology and 7Medicine, Weill Cornell Medical College, New York, New York; and 8Centro de Investigación y de Estudios Avanzados del IPN, Unidad Monterrey, Apodaca, México; Authors' Affiliations: 1Department of Nanomedicine, The Methodist Hospital Research Institute; 2Departments of Experimental Therapeutics, 3Gynecologic Oncology, and 4Cancer Biology, 5Center for RNA Interference and Non-coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; Departments of 6Cell and Developmental Biology and 7Medicine, Weill Cornell Medical College, New York, New York; and 8Centro de Investigación y de Estudios Avanzados del IPN, Unidad Monterrey, Apodaca, México 1Gynecologic Oncology, Departments of; 3Cancer Biology, The University of Texas M. D. Anderson Cancer Center; 1Gynecologic Oncology, Departments of; 3Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, Texas and Departments of Gynecological Oncology and Cancer Biology University of Texas MD Anderson Cancer Center Houston TX USA; Center for RNA Interference and Non‐Coding RNA University of Texas MD Anderson Cancer Center Houston TX USA Gynecologic Oncology and Reproductive Medicine, and; Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 2Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 4Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 3Departments of Gynecologic Oncology and Cell Biology, M.D. Anderson Cancer Center, Houston, Texas Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Hematology and Oncology, 3Biostatistics, 4Cancer Biology, and 5Pathology, and 6The Center for RNA Interference and Non-Coding RNAs; The University of Texas MD Anderson Cancer Center, Houston, Texas; Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Hematology and Oncology, 3Biostatistics, 4Cancer Biology, and 5Pathology, and 6The Center for RNA Interference and Non-Coding RNAs; The University of Texas MD Anderson Cancer Center, Houston, Texas; Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Hematology and Oncology, 3Biostatistics, 4Cancer Biology, and 5Pathology, and 6The Center for RNA Interference and Non-Coding RNAs; The University of Texas MD Anderson Cancer Center, Houston, Texas Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States;; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States;; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States; 9Departments of Gynecologic Oncology and Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas Authors' Affiliations: 1College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, PR China; Departments of 2Experimental Diagnostic Imaging, 3Diagnostic Radiology, 4Gynecologic Oncology, and 5Cancer Biology, 6Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; Authors' Affiliations: 1College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, PR China; Departments of 2Experimental Diagnostic Imaging, 3Diagnostic Radiology, 4Gynecologic Oncology, and 5Cancer Biology, 6Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; Authors' Affiliations: 1College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, PR China; Departments of 2Experimental Diagnostic Imaging, 3Diagnostic Radiology, 4Gynecologic Oncology, and 5Cancer Biology, 6Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Deparment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Iowa, University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242-1109, USA. [email protected] Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Departments of Gynecologic Oncology and Cancer Biology and Center for RNA Interference and Non‐Coding RNA University of Texas MD Anderson Cancer Center Houston Texas Authors' Affiliations: Departments of 1Experimental Therapeutics, 2Gynecologic Oncology, 3Systems Biology, 4Cancer Biology, and 5Center for RNAi and non-coding-RNA, University of Texas M. D. Anderson Cancer Center; and 6Department of Bioengineering and Division of Applied Physics, Rice University, Houston, Texas; 7University of Puerto Rico Comprehensive Cancer Center, Rio Piedras, Puerto Rico; 8Centro de Investigación y de Estudios Avanzados del IPN, Unidad Monterrey, PIIT, Apodaca NL, Mexico; and 9Division of Gynecologic Oncology, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Columbia, Canada; Authors' Affiliations: Departments of 1Experimental Therapeutics, 2Gynecologic Oncology, 3Systems Biology, 4Cancer Biology, and 5Center for RNAi and non-coding-RNA, University of Texas M. D. Anderson Cancer Center; and 6Department of Bioengineering and Division of Applied Physics, Rice University, Houston, Texas; 7University of Puerto Rico Comprehensive Cancer Center, Rio Piedras, Puerto Rico; 8Centro de Investigación y de Estudios Avanzados del IPN, Unidad Monterrey, PIIT, Apodaca NL, Mexico; and 9Division of Gynecologic Oncology, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Columbia, Canada; Authors' Affiliations: Departments of 1Experimental Therapeutics, 2Gynecologic Oncology, 3Systems Biology, 4Cancer Biology, and 5Center for RNAi and non-coding-RNA, University of Texas M. D. Anderson Cancer Center; and 6Department of Bioengineering and Division of Applied Physics, Rice University, Houston, Texas; 7University of Puerto Rico Comprehensive Cancer Center, Rio Piedras, Puerto Rico; 8Centro de Investigación y de Estudios Avanzados del IPN, Unidad Monterrey, PIIT, Apodaca NL, Mexico; and 9Division of Gynecologic Oncology, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Columbia, Canada Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston11Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston Authors' Affiliations: Departments of 1Gynecology Oncology,; 3Cancer Biology;; 4Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center (MDACC); Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Authors' Affiliations: Departments of 1Obstetrics and Gynecology, 2Radiation Oncology, and 3Pathology, University of Alabama at Birmingham, Birmingham, Alabama; 4Center for RNA Interference and Non-Coding RNA, Departments of 5Experimental Therapeutics, 6Cancer Biology, and 7Gynecologic Oncology & Reproductive Medicine, U.T.M.D. Anderson Cancer Center, Houston, Texas; Authors' Affiliations: Departments of 1Obstetrics and Gynecology, 2Radiation Oncology, and 3Pathology, University of Alabama at Birmingham, Birmingham, Alabama; 4Center for RNA Interference and Non-Coding RNA, Departments of 5Experimental Therapeutics, 6Cancer Biology, and 7Gynecologic Oncology & Reproductive Medicine, U.T.M.D. Anderson Cancer Center, Houston, Texas; Authors' Affiliations: Departments of 1Obstetrics and Gynecology, 2Radiation Oncology, and 3Pathology, University of Alabama at Birmingham, Birmingham, Alabama; 4Center for RNA Interference and Non-Coding RNA, Departments of 5Experimental Therapeutics, 6Cancer Biology, and 7Gynecologic Oncology & Reproductive Medicine, U.T.M.D. Anderson Cancer Center, Houston, Texas 1Gynecologic Oncology and Departments of; 2Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, Texas; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 2Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 6Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 10Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas. †Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030;; §Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; and; ¶Center for RNA Intereference and Non-Coding RNAs, University of Texas MD Anderson Cancer Center, Houston, TX 77030 1Gynecologic Oncology, Departments of; 3Cancer Biology, University of Texas M. D. Anderson Cancer Center, and Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Cancer Biology, 3Pathology, and 4Experimental Therapeutics, 5Center for RNAi and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and 6Center for Reproductive Sciences, University of California, San Francisco, California; Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Cancer Biology, 3Pathology, and 4Experimental Therapeutics, 5Center for RNAi and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and 6Center for Reproductive Sciences, University of California, San Francisco, California; Authors' Affiliations: Departments of 1Gynecologic Oncology, 2Cancer Biology, 3Pathology, and 4Experimental Therapeutics, 5Center for RNAi and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; and 6Center for Reproductive Sciences, University of California, San Francisco, California 1Gynecologic Oncology, Departments of; 3Cancer Biology, and 5Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 6Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 5Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 9Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA; Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA; Center for RNA Interference and Non-coding RNA, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Experimental Therapeutics, and 3Cancer Biology; 4The Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; 5Five Prime Therapeutics, Inc, South San Francisco, California; and 6Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Experimental Therapeutics, and 3Cancer Biology; 4The Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; 5Five Prime Therapeutics, Inc, South San Francisco, California; and 6Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine, 2Experimental Therapeutics, and 3Cancer Biology; 4The Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas; 5Five Prime Therapeutics, Inc, South San Francisco, California; and 6Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 12Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas. Departments of Gyn Onc and Reproductive Medicine and Cancer Biology; The University of Texas MD Anderson Cancer Center; Houston, TX USA University of Texas MD Anderson Cancer Center Houston Texas 4Gynecologic Oncology,; 5Cancer Biology, and Authors' Affiliations: 1Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, and 2Bioinformatics and Computational Biosciences Branch, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland; 3Division of Pathology, Norwegian Radium Hospital, Oslo University Hospital, and The Medical Faculty, University of Oslo; 4Department of Gynecologic Oncology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; 5Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio; 6Departments of Gynecologic Oncology and Cancer Biology, and Center for RNA Interference and Non-Coding RNA, University of Texas MD Anderson Cancer Center, Houston, Texas; 7Fox Chase Cancer Center, Philadelphia, Pennsylvania; and 8Vincent Center for Reproductive Biology, Vincent Obstetrics and Gynecology Service, Massachusetts General Hospital, Boston, Massachusetts 2Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 5Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 6Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas. From the Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA; University of Texas M. D. Anderson Comprehensive Cancer Center, Houston, TX; and the Sylvester Cancer Center, University of Miami, Miami, FL. 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 6Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; The Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Departments of Gynecologic Oncology and Reproductive Medicine and Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Gynecologic Oncology and Reproductive Medicine and Center for RNAi and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA and 1Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 3Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 4Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, Texas. Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine and 2Cancer Biology, 3Center for RNA Interference and Non-Coding RNA, the University of Texas MD Anderson Cancer Center, Houston, Texas; 4University of Southern California, Los Angeles, California; 5Department of Obstetrics and Gynecology, Dongguk University; Departments of 6Systems Biology and 7Obstetrics and Gynecology, Konkuk University, Seoul, Korea; and 8Department of Obstetrics and Gynecology, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine and 2Cancer Biology, 3Center for RNA Interference and Non-Coding RNA, the University of Texas MD Anderson Cancer Center, Houston, Texas; 4University of Southern California, Los Angeles, California; 5Department of Obstetrics and Gynecology, Dongguk University; Departments of 6Systems Biology and 7Obstetrics and Gynecology, Konkuk University, Seoul, Korea; and 8Department of Obstetrics and Gynecology, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine and 2Cancer Biology, 3Center for RNA Interference and Non-Coding RNA, the University of Texas MD Anderson Cancer Center, Houston, Texas; 4University of Southern California, Los Angeles, California; 5Department of Obstetrics and Gynecology, Dongguk University; Departments of 6Systems Biology and 7Obstetrics and Gynecology, Konkuk University, Seoul, Korea; and 8Department of Obstetrics and Gynecology, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center , Houston, TX , USA From the Departments of Gynecologic Oncology, Biostatistics and Applied Mathematics, and Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, IA Program in Cancer Biology and Cancer Metastasis, The University of Texas Graduate School of Biomedical Sciences at Houston, TX, USA; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Authors' Affiliation: Departments of 1Gynecologic Oncology,2Genitourinary Medical Oncology, 3Experimental Therapeutics, and 4Cancer Biology, and 5Center for RNA Interference and Noncoding RNA, The University of Texas M.D. Anderson Cancer Center; and 6Department of Radiation Biophysics, University of Space Research Association, NASA Johnson Space Center, Houston, Texas; 7Department of Obstetrics and Gynecology, Division of Gynecologic Oncology and UW Carbone Cancer Center, University of Wisconsin, Madison, Wisconsin; 8Department of Pathology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine; 9Women's Cancer Clinic, Department of Obstetrics and Gynecology, Yonsei University College of Medicine; 10Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine; and 11Department of Obstetrics and Gynecology, Konkuk University Hospital, Konkuk University School of Medicine, Seoul, Korea; and 12Department of Obstetrics & Gynec; Authors' Affiliation: Departments of 1Gynecologic Oncology,2Genitourinary Medical Oncology, 3Experimental Therapeutics, and 4Cancer Biology, and 5Center for RNA Interference and Noncoding RNA, The University of Texas M.D. Anderson Cancer Center; and 6Department of Radiation Biophysics, University of Space Research Association, NASA Johnson Space Center, Houston, Texas; 7Department of Obstetrics and Gynecology, Division of Gynecologic Oncology and UW Carbone Cancer Center, University of Wisconsin, Madison, Wisconsin; 8Department of Pathology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine; 9Women's Cancer Clinic, Department of Obstetrics and Gynecology, Yonsei University College of Medicine; 10Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine; and 11Department of Obstetrics and Gynecology, Konkuk University Hospital, Konkuk University School of Medicine, Seoul, Korea; and 12Department of Obstetrics & Gynec; Authors' Affiliation: Departments of 1Gynecologic Oncology,2Genitourinary Medical Oncology, 3Experimental Therapeutics, and 4Cancer Biology, and 5Center for RNA Interference and Noncoding RNA, The University of Texas M.D. Anderson Cancer Center; and 6Department of Radiation Biophysics, University of Space Research Association, NASA Johnson Space Center, Houston, Texas; 7Department of Obstetrics and Gynecology, Division of Gynecologic Oncology and UW Carbone Cancer Center, University of Wisconsin, Madison, Wisconsin; 8Department of Pathology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine; 9Women's Cancer Clinic, Department of Obstetrics and Gynecology, Yonsei University College of Medicine; 10Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine; and 11Department of Obstetrics and Gynecology, Konkuk University Hospital, Konkuk University School of Medicine, Seoul, Korea; and 12Department of Obstetrics & Gynec Authors' Affiliations: Departments of 1Gynecologic Oncology and 2Cancer Biology, and 3Center for RNAi and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas; and Departments of 4Psychology, 5Obstetrics & Gynecology, and 6Urology, and 7Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa; Authors' Affiliations: Departments of 1Gynecologic Oncology and 2Cancer Biology, and 3Center for RNAi and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas; and Departments of 4Psychology, 5Obstetrics & Gynecology, and 6Urology, and 7Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa; Authors' Affiliations: Departments of 1Gynecologic Oncology and 2Cancer Biology, and 3Center for RNAi and Non-Coding RNA, MD Anderson Cancer Center, Houston, Texas; and Departments of 4Psychology, 5Obstetrics & Gynecology, and 6Urology, and 7Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa |
Incoming Links
Showing number of triples: 1 to 996 of 996.